erlotinib has been researched along with niclosamide in 1 studies
Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (niclosamide) | Trials (niclosamide) | Recent Studies (post-2010) (niclosamide) |
---|---|---|---|---|---|
221 | 0 | 180 | 979 | 19 | 465 |
Protein | Taxonomy | erlotinib (IC50) | niclosamide (IC50) |
---|---|---|---|
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 13.7 | |
Tyrosine-protein kinase JAK2 | Homo sapiens (human) | 10 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.28 | |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 10 | |
Signal transducer and activator of transcription 3 | Homo sapiens (human) | 0.23 | |
Anoctamin-1 | Homo sapiens (human) | 0.028 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
1 review(s) available for erlotinib and niclosamide
Article | Year |
---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |